Skip to content

Author

Si-Ling Wang

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Carbon monoxide-releasing mesoporous polydopamine nanoplatform for lysosomal disruption and synergistic tumor therapy.

Lysosomes, pivotal in tumor progression and therapy resistance, sustain cancer survival through drug tolerance and stress adaptation. Conventional lysosome-disrupting approaches faced transient efficacy from poor targeting or cellular repair mechanisms. To address this, we engineered a biomimetic nanoplatform (FeCO@MP-...

Shuai-Peng Feng, Lu-Ping Sha, Zi-Wei Yan et al. · 0 citations
Review Oct 2026

Current Advances in Antioxidant Nanozymes for Liver Diseases.

The liver with unique physiological functions is susceptible to oxidative stress (OS) damage from reactive oxygen species (ROS) accumulation, further triggering various liver diseases. Compared with conventional pharmacological and surgical therapies, natural antioxidant enzymes represent promise for liver disease ther...

Jin-Ya Xiong, Zhu Liu, Yi-Duo Ding et al. · 0 citations
Review Oct 2026

Recent advances in antioxidant nanozymes for the treatment of inflammatory bowel disease.

To overcome biopharmaceutical bottlenecks, an overview of nanozyme-based intelligent delivery platforms tailored for the inflamed gut are provided, covering endogenous/exogenous stimuli-responsive, biomimetic, and microbiota-mediated systems.

Zuo-Yi Shen, Shi-Qiao Rui, Jing-Qi Zhang et al. · 0 citations
Sep 2026

Targeting Tumor–CAFs Crosstalk to Reverse Drug Resistance and Immunosuppression Through Cuproptosis

Chemotherapy resistance and immunosuppression are the current key bottlenecks in tumor treatment. In the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) secrete dense extracellular matrix and various immunosuppressive factors, forming a dynamic “tumor–CAFs crosstalk”, which drives the progression o...

Qing-Qing Xu, Shuai-Peng Feng, Dong-Lin Bian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.